MIP-DILI
Eli Lilly and Company Limited , Orion Corporation (Finland) , UR1 , Utrecht University , KI , KLC , KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN , H. LUNDBECK A/S , VUA , Leiden University , BMS , SARD , AbbVie , Interface Europe (Belgium) , Universitäts-Augenklinik Bonn , UCB , GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. , MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN , AstraZeneca (Sweden) , Takara Bio Europe AB , ...
Start a new DMP in Loading
Eli Lilly and Company Limited , Orion Corporation (Finland) , UR1 , Utrecht University , KI , KLC , KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN , H. LUNDBECK A/S , VUA , Leiden University , BMS , SARD , AbbVie , Interface Europe (Belgium) , Universitäts-Augenklinik Bonn , UCB , GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. , MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN , AstraZeneca (Sweden) , Takara Bio Europe AB , SOLVO BIOTECHNOLOGY , University of Liverpool , CXR BIOSCIENCES LIMITED , GERMAN CANCER RESEARCH CENTER , University of Freiburg , LL , IRIS , Janssen (Belgium)
<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=corda_______::11971d2a464dff06db0db6c070612907&type=result"></script>');
-->
</script> For further information contact us at helpdesk@openaire.eu